Stocks
BioCryst Pharmaceuticals, Inc.BCRX
NASDAQHealthcareBiotechnology$8.22-1.91%
A biotechnology company focused on developing oral small‑molecule therapies for rare diseases, with a commercial product targeting hereditary angioedema. Revenue is driven primarily by Orladeyo, a once‑daily oral prophylactic treatment, while the pipeline includes additional programs in complement‑m...
Market Cap: $1.7B52W Range: $6.00 – $11.31
Congressional Interest in BioCryst Pharmaceuticals, Inc. (BCRX)
3 members of Congress have disclosed 5 trades in BioCryst Pharmaceuticals, Inc. (BCRX), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
5
Unique Politicians
3
Buys
3
Sells
2
Who in Congress Is Trading BCRX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-11-13 | Gilbert Cisneros | buy | $1K – $15K |
| 2023-10-16 | Josh Gottheimer | buy | $1K – $15K |